FDA Inspection 1224648 — Tennessee Reproductive Medicine
The FDA completed an inspection of Tennessee Reproductive Medicine on Dec 5, 2023 in Chattanooga, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 5, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Chattanooga, TN (United States)